Filing Details
- Accession Number:
- 0001104659-16-154726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-03 21:35:34
- Reporting Period:
- 2016-11-01
- Filing Date:
- 2016-11-03
- Accepted Time:
- 2016-11-03 21:35:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Ophthotech Corp. | OPHT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277476 | R David Guyer | C/O Ophthotech Corporation One Penn Plaza, 19Th Floor New York NY 10119 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-01 | 22,060 | $10.03 | 24,541 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-01 | 10,530 | $34.93 | 14,011 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-11-01 | 7,710 | $35.93 | 6,301 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-11-01 | 3,820 | $36.86 | 2,481 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2016-11-01 | 22,060 | $0.00 | 22,060 | $10.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 105,636 | 2023-04-25 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2015.
- These shares were disposed of in multiple transactions on November 1, 2016 at actual sales prices ranging from $34.38 to $35.32 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were disposed of in multiple transactions on November 1, 2016 at actual sales prices ranging from $35.41 to $36.40 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were disposed of in multiple transactions on November 1, 2016 at actual sales prices ranging from $36.41 to $37.305 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017.
- Represents the aggregate number of options remaining from each of two awards that were granted to the Reporting Person on April 26, 2013, each of which has an expiration date of April 25, 2023 and an exercise price of $10.03 per option. These two awards were previously reported separately by the Reporting Person.
Billionaire Hedge Funds
